Clinical and Prognostic Significance of Protocadherin-10 (PCDH10) Promoter Methylation in Bladder Cancer

Author： Lin YL   Li ZG   He ZK   Guan TY   Ma JG  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.40, Iss.6, 2012-11, pp. : 2117-2123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Significance of CDH13 Promoter Methylation in Serum Samples from Patients with Bladder Transitional Cell Carcinoma

By Lin YL   Sun G   Liu XQ   Li WP   Ma JG  

The Journal of International Medical Research, Vol. 39, Iss. 1, 2011-01 ,pp. : 179-186

Field House Publishing

Access to resources Recommend Favorite

Frequent SLIT2 Promoter Methylation in the Serum of Patients with Ovarian Cancer

By Dong R   Yu J   Pu H   Zhang Z   Xu X  

The Journal of International Medical Research, Vol. 40, Iss. 2, 2012-03 ,pp. : 681-686

Field House Publishing

Access to resources Recommend Favorite

Expression and Clinical Significance of SHP2 in Gastric Cancer

By Dong S   Li F-Q   Zhang Q   Lv K-Z   Yang H-L   Gao Y   Yu J-R  

The Journal of International Medical Research, Vol. 40, Iss. 6, 2012-11 ,pp. : 2083-2089

Field House Publishing

Access to resources Recommend Favorite

Genetic Polymorphisms of MTHFR and Aberrant Promoter Hypermethylation of the RASSF1A Gene in Bladder Cancer Risk in a Chinese Population

By Cai DW   Liu XF   Bu RG   Chen XN   Ning L   Cheng Y   Wu B  

The Journal of International Medical Research, Vol. 37, Iss. 6, 2009-11 ,pp. : 1882-1889

Field House Publishing

Access to resources Recommend Favorite

Interleukin-10 −819 Promoter Polymorphism Associated with Gastric Cancer among Asians

By Chen K-F   Li B   Wei Y-G   Peng C-J  

The Journal of International Medical Research, Vol. 38, Iss. 1, 2010-01 ,pp. : 1-8

Field House Publishing

Access to resources Recommend Favorite